About Alcresta
Alcresta is a company based in Newton (United States) founded in 2011 was acquired by Linden Capital Partners in March 2024.. Alcresta has raised $95.89 million across 6 funding rounds from investors including Bessemer Venture Partners, Frazier Healthcare Partners and Athyrium Capital Management. The company has 52 employees as of December 31, 2022. Alcresta offers products and services including RELiZORB and iLipase. Alcresta operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Seed, among others.
- Headquarter Newton, United States
- Employees 52 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alcresta Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$95.89 M (USD)
in 6 rounds
-
Latest Funding Round
$10 M (USD), Series D
Feb 28, 2020
-
Investors
Bessemer Venture Partners
& 4 more
-
Employee Count
52
as on Dec 31, 2022
-
Acquired by
Linden Capital Partners
(Mar 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alcresta
Alcresta offers a comprehensive portfolio of products and services, including RELiZORB and iLipase. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Breaks down fats in enteral feeding for better absorption in patients.
Patented microbead technology for fat digestion in nutritional support.
Unlock access to complete
Funding Insights of Alcresta
Alcresta has successfully raised a total of $95.89M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $10.0M
-
First Round
First Round
(17 Apr 2012)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Series D - Alcresta | Valuation |
investors |
|
| Jan, 2019 | Amount | Series D - Alcresta | Valuation |
investors |
|
| Sep, 2017 | Amount | Series D - Alcresta | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alcresta
Alcresta has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, Frazier Healthcare Partners and Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Founded Year | Domain | Location | |
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alcresta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alcresta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alcresta Comparisons
Competitors of Alcresta
Alcresta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Seed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alcresta
Frequently Asked Questions about Alcresta
When was Alcresta founded?
Alcresta was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Alcresta located?
Alcresta is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Who is the current CEO of Alcresta?
Daniel Orlando is the current CEO of Alcresta.
Is Alcresta a funded company?
Alcresta is a funded company, having raised a total of $95.89M across 6 funding rounds to date. The company's 1st funding round was a Series D of $10M, raised on Apr 17, 2012.
How many employees does Alcresta have?
As of Dec 31, 2022, the latest employee count at Alcresta is 52.
What does Alcresta do?
Alcresta was founded in 2011 in Newton, United States, focusing on the biotechnology sector for gastrointestinal health. A platform technology is utilized to immobilize enzymes on insoluble carriers, aiding digestion and nutrient absorption. The flagship product, Relizorb, is designed as a cartridge mimicking pancreatic lipase function. Operations center on developing and advancing these enzyme-based therapeutics for clinical applications.
Who are the top competitors of Alcresta?
Alcresta's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
What products or services does Alcresta offer?
Alcresta offers RELiZORB and iLipase.
Who are Alcresta's investors?
Alcresta has 5 investors. Key investors include Bessemer Venture Partners, Frazier Healthcare Partners, Athyrium Capital Management, Third Rock Ventures, and Linden Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.